CFAH VHIO – Vall d'Hebron Institute of Oncology

ABOUT VHIO

VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer:

DISCOVER MORE

PROGRAMS & GROUPS

Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing and rapidly translating discoveries into tangible benefits for patients.

MEET VHIO´S TEAMS

NEWS

Reflective of their exceptional contributions to cancer science, VHIO’s Josep Tabernero, Enriqueta Felip & Javier Cortés feature among Clarivate’s Highly Cited Researchers 2021

16/11/2021|Comments Off on Reflective of their exceptional contributions to cancer science, VHIO’s Josep Tabernero, Enriqueta Felip & Javier Cortés feature among Clarivate’s Highly Cited Researchers 2021

Celebrating the launch of World Cancer Day’s new campaign: Close the Care Gap

10/11/2021|Comments Off on Celebrating the launch of World Cancer Day’s new campaign: Close the Care Gap

The 12th annual WIN Symposium 2022: a scientific program par excellence

29/10/2021|Comments Off on The 12th annual WIN Symposium 2022: a scientific program par excellence

Seeking out predictive biomarkers to FGFR inhibitors in molecularly-selected metastatic breast cancer

27/10/2021|Comments Off on Seeking out predictive biomarkers to FGFR inhibitors in molecularly-selected metastatic breast cancer

VHIO’s Enriqueta Felip takes up the reins as SEOM President (2021-2023)

22/10/2021|Comments Off on VHIO’s Enriqueta Felip takes up the reins as SEOM President (2021-2023)

VHIO investigators co-author new ESMO Clinical Practice Guideline with evidence-based recommendations for the treatment of metastatic breast cancer

21/10/2021|Comments Off on VHIO investigators co-author new ESMO Clinical Practice Guideline with evidence-based recommendations for the treatment of metastatic breast cancer

SEE ALL NEWS

Follow us:

DIRECTION &
PRINCIPAL INVESTIGATORS

Research at VHIO is led by our Director, Josep Tabernero, and supported by a consultative body, VHIO’s Scientific Committee. A total of 26 renowned Principal Investigators manage and run VHIO’s major research themes and programs.

BROWSE OUR PIS

SCIENTIFIC
REPORT
2020

LAUNCH

CLINICAL TRIALS

Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept to clinic:

CLINICAL TRIALS OFFICE
RESEARCH UNIT FOR MOLECULAR THERAPY OF CANCER (UITM) – CAIXARESEARCH
CURRENTLY OPEN TRIALS

PROJECTS & INSTITUTIONAL PROGRAMS

Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:

CURRENT PROJECTS
FERO FOUNDATION’S ADVANCED MOLECULAR DIAGNOSTICS PROGRAM
BBVA FOUNDATION’S IMMUNOTHERAPY & IMMUNOLOGY PROGRAM (CAIMI)
“LA CAIXA” INTL RESEARCH & EDUCATION PROGRAM
SCIENTIFIC COORDINATION

EVENTS

VHIO organizes symposia of excellence and ad-hoc courses & workshops through which it shares its expertise and promotes debate and exchange of the highest degree:

VHIO – ”LA CAIXA” SCIENTIFIC SEMINARS SERIES
INTERNATIONAL SYMPOSIA
WORKSHOPS & COURSES
BENCHSTORMING SEMINARS